Published in J Immunol on July 01, 1963
Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion. Proc Natl Acad Sci U S A (1970) 11.83
Ribonucleic acid synthesis of vesicular stomatitis virus. I. Species of ribonucleic acid found in Chinese hamster ovary cells infected with plaque-forming and defective particles. J Virol (1969) 5.73
Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis. J Virol (1970) 4.85
Structural proteins of vesicular stomatitis viruses. J Virol (1969) 4.70
Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus. J Virol (1979) 3.54
Lipid composition of purified vesicular stomatitis viruses. J Virol (1971) 3.25
Localization of two cellular forms of the vesicular stomatitis viral glycoprotein. J Virol (1977) 3.20
Translation of vesicular stomatitis messenger RNA by extracts from mammalian and plant cells. J Virol (1974) 3.06
Nucleotide sequence complexities, molecular weights, and poly(A) content of the vesicular stomatitis virus mRNA species. J Virol (1975) 2.85
Spatial relationships of the proteins of vesicular stomatitis virus: induction of reversible oligomers by cleavable protein cross-linkers and oxidation. J Virol (1977) 2.77
Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells. J Exp Med (1967) 2.46
Inhibition of cellular RNA synthesis by nonreplicating vesicular stomatitis virus. Proc Natl Acad Sci U S A (1965) 2.37
Oligonucleotide fingerprints of RNA species obtained from rhabdoviruses belonging to the vesicular stomatitis virus subgroup. J Virol (1977) 2.35
Persistent noncytocidal vesicular stomatitis virus infections mediated by defective T particles that suppress virion transcriptase. Proc Natl Acad Sci U S A (1974) 2.34
Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell cultures. J Virol (1972) 2.09
Relative sensitivities of viruses to different species of interferon. J Virol (1969) 2.02
Factors affecting the sensitivity of different viruses to interferon. J Virol (1970) 1.96
Association of vesicular stomatitis virus glycoprotein with virion membrane: characterization of the lipophilic tail fragment. J Virol (1975) 1.88
Interferon production and inhibition of host synthesis in cells infected with vesicular stomatitis virus. J Virol (1970) 1.71
Role of temperature-sensitive mutants in persistent infections initiated with vesicular stomatitis virus. J Virol (1976) 1.68
Sialoglycoprotein of vesicular stomatitis virus: role of the neuraminic acid in infection. J Virol (1974) 1.63
Differential inhibition of host protein synthesis in L cells infected with RNA - temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1976) 1.55
Inhibition of RNA synthesis in mouse myeloma cells infected with vesicular stomatitis virus. J Virol (1978) 1.51
Aberrant polyadenylation by a vesicular stomatitis virus mutant is due to an altered L protein. J Virol (1984) 1.46
Rubella virus carrier cultures derived from congenitally infected infants. J Exp Med (1966) 1.45
RNA- temperature-sensitive mutants of vesicular stomatitis virus: L-protein thermosensitivity accounts for transcriptase restriction of group I mutants. J Virol (1976) 1.44
Use of UV irradiation to identify the genetic information of vesicular stomatitis virus responsible for shutting off cellular RNA synthesis. J Virol (1979) 1.44
Screening procedure for complementation-dependent mutants of vesicular stomatitis virus. J Virol (1975) 1.40
Accumulation of chlamydial lipopolysaccharide antigen in the plasma membranes of infected cells. Infect Immun (1989) 1.30
Inhibition by aurintricarboxylic acid and polyethylene sulfonate of RNA transcription of vesicular stomatitis virus. J Virol (1975) 1.21
Cellular adsorption function of the sialoglycoprotein of vesicular stomatitis virus and its neuraminic acid. J Virol (1975) 1.19
Use of antiviral-antiferritin hybrid antibody for localization of viral antigen in plasma membrane. J Virol (1971) 1.15
Synthesis of a small RNA in cells coinfected by standard and defective interfering particles of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1979) 1.15
Characterization of hog cholera virus. I. Determination of buoyant density. J Bacteriol (1966) 1.15
INTERFERON PRODUCTION AND SENSITIVITY OF SEMLIKI FOREST VIRUS VARIANTS. J Hyg (Lond) (1964) 1.13
Comparative inhibition of cellular transcription by vesicular stomatitis virus serotypes New Jersey and Indiana: role of each viral leader RNA. J Virol (1983) 1.13
Inhibition of Mengo virus by interferon. J Bacteriol (1966) 1.10
Isolation and characterization of an equine rotavirus. J Clin Microbiol (1983) 1.07
Viruses isolated from cells persistently infected with vesicular stomatitis virus show altered interactions with defective interfering particles. J Virol (1980) 1.05
Asymmetric distribution of phosphatidylethanolamine in the membrane of vesicular stomatitis virus. J Virol (1976) 1.03
Vesicular stomatitis virus growth in Drosophila melanogaster cells: G protein deficiency. J Virol (1980) 1.02
Interferon sensitivity of Venezuelan equine encephalomyelitis virus. Infect Immun (1973) 1.01
Transcribing complexes in cells infected by vesicular stomatitis virus and rabies virus. J Virol (1974) 1.00
RNA synthesis of vesicular stomatitis virus. X. Transcription and replication by defective interfering particles. J Virol (1980) 0.95
Vesicular stomatitis virus mutant with altered polyadenylic acid polymerase activity in vitro. J Virol (1983) 0.92
Studies on persistent infections of tissue culture. VI. Reversible changes in Newcastle disease virus populations as a result of passage in L cells or chick embryos. J Virol (1967) 0.91
The influence of cortisone on experimental viral infection. VII. Kinetics of interferon formation and its inhibition with hydrocortisone in relation to viral strain and virulence. J Exp Med (1966) 0.89
Effects of temperature and antibody on the cyclid growth of vesicular stomatitis virus. J Virol (1977) 0.83
Incorporation of L cell sterols into vesicular stomatitis virus. J Virol (1972) 0.83
Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons. Infect Immun (1977) 0.81
High-Throughput Single-Cell Kinetics of Virus Infections in the Presence of Defective Interfering Particles. J Virol (2015) 0.80
Characterization of vesicular stomatitis virus populations by tunable resistive pulse sensing. J Virol Methods (2015) 0.80
Experimentally induced alterations in antigenic properties of an arbovirus serotype. Infect Immun (1970) 0.77
Evidence that vesicular stomatitis virus produces double-stranded RNA that inhibits protein synthesis in a reticulocyte lysate. J Virol (1982) 0.75
Biological studies of interferon. I. Suppression of cellular infection with eastern equine encephalomyelitis virus. Virology (1961) 3.92
PENETRATION OF HERPES SIMPLEX VIRUS INTO HUMAN EPIDERMOID CELLS. Proc Soc Exp Biol Med (1965) 2.42
The production of fever by influenzal viruses; factors influencing the febrile response to single injections of virus. J Exp Med (1949) 2.04
INHIBITION OF INTERFERON BIOSYNTHESIS BY ACTINOMYCIN D. Nature (1964) 1.73
A pantropic strain of influenza virus: generalized infection and viremia in the infant mouse. Virology (1955) 1.62
INTERFERON. A REVIEW AND ANALYSIS OF RECENT OBSERVATIONS. Am J Med (1965) 1.54
An epizootic in Swiss mice caused by a group A Streptococcus, newly designated type 50. Am J Hyg (1960) 1.54
Pyrogenicity of influenza virus in rabbits. Proc Soc Exp Biol Med (1949) 1.32
Biological studies of interferon. II. Temporal relationships of virus and interferon production by cells infected with Eastern equine encephalomyelitis and influenza viruses. Virology (1963) 1.24
The production of fever by influenzal viruses; tolerance in rabbits to the pyrogenic effect of influenzal viruses. J Exp Med (1949) 1.21
The resistance-promoting activity of endotoxins and other microbial products. I. Their effect on Salmonella typhosa infections of mice. J Immunol (1959) 1.17
Cellular resistance to viral infection, with particular reference to endogenous interferon. Bacteriol Rev (1963) 1.17
The production of fever by influenzal viruses; effect of receptor-destroying substances. J Exp Med (1950) 1.16
Interferon as a chemical intermediary in viral interference. Ann N Y Acad Sci (1960) 1.08
The resistance-promoting activity of endotoxins and other microbial products. II. Protection against the neurotoxic action of infleunza virus. J Immunol (1959) 1.07
Increased avidity of antibody for Baltimore 1957 strains of Asian influenza virus (P-Q-R variation). Proc Soc Exp Biol Med (1958) 0.99
Effect of bacterial endotoxin on resistance of mice to viral encephalitides; including comparative studies of the interference phenomenon. J Immunol (1959) 0.98
Studies on the pathogenesis of influenzal pneumonitis; intranasal vs. intravenous infection of mice. Yale J Biol Med (1956) 0.98
Side effects accompanying use of iproniazid. Am Rev Tuberc (1953) 0.94
Studies on the inactivation of influenza virus; comparison of the effects of p-benzoquinone and various inorganic oxidizing agents. Yale J Biol Med (1951) 0.94
Toxicity of bacterial endotoxins for the chicken embryo: pathological and biological studies. Bull Johns Hopkins Hosp (1961) 0.93
Hemorrhagic encephalopathy in chicken embryos infected with influenza virus. IV. Endothelial localization of viral antigens determined by immunofluorescence. Am J Pathol (1962) 0.90
THE INTERFERONS: CELLULAR INHIBITORS OF VIRAL INFECTION. Annu Rev Microbiol (1963) 0.89
Acquired resistance to bacterial infection in insects. Bacteriol Rev (1961) 0.89
Viral interference induced in mice by acute or persistent infection with the virus of lymphocytic choriomeningitis. Nature (1962) 0.88
Production of fever by influenzal viruses. V. Effect of nitrogen mustard (HN2). Bull Johns Hopkins Hosp (1955) 0.86
Hemorrhagic encephalopathy in chicken embryos infected with influenza virus. III. Viral interference at a distant site induced by prior allantoic infection. J Immunol (1962) 0.86
Hemorrhagic encephalopathy in chicken embryos infected with influenza virus. I. Factors influencing the development of hemorrhages. Bull Johns Hopkins Hosp (1958) 0.85
Acquired resistance in mice to the neurotoxic action of influenza viruses. Br J Exp Pathol (1952) 0.84
Cytotoxic action of influenza virus; failure to induce acquired resistance phenomenon in tissue culture. Proc Soc Exp Biol Med (1955) 0.84
Hemorrhagic encephalopathy in chicken embryos infected with influenza virus. II. Pathology. Bull Johns Hopkins Hosp (1958) 0.82
Production of fever by influenzal viruses. IV. Tolerance to mumps and influenza pyrogens. Proc Soc Exp Biol Med (1953) 0.79
THE INTERFERONS: BIOLOGIC BASIS FOR THEIR ROLE IN VIRAL INFECTIONS. Postgrad Med (1964) 0.79
Age and susceptibility to neurotropic influenza virus. Proc Soc Exp Biol Med (1954) 0.78
CHEMICAL AND BIOLOGIC APPROACHES TO THE THERAPY OF VIRAL DISEASES. Am Rev Respir Dis (1963) 0.76
Influenza virus infection of transplanted tumors. I. Multiplication of a neurotropic strain and its effect on solid neoplasms. Cancer Res (1954) 0.75
Influenza virus infection of transplanted tumors. III. Effect of passive immunization on infections of the Ehrlich ascites tumor. J Immunol (1955) 0.75
Influenza virus infection of transplanted tumors. II. The relation of host immunity to virus action. J Immunol (1955) 0.75
The basic medical sciences, the revolution in biology and the future of medical education. Yale J Biol Med (1962) 0.75
SCHISMS IN CLINICAL AND BASIC MICROBIOLOGY. J Med Educ (1964) 0.75
Clinical observations on terramycin. Yale J Biol Med (1950) 0.75
Virus absorption by tumor cells. Proc Soc Exp Biol Med (1955) 0.75
Influenza virus multiplication in homologously transplanted mouse fetal tissues. J Immunol (1953) 0.75
[Clinical observations on terramycin]. Sem Med (1951) 0.75